MEGGLE heads to Colombia for Farmacosmética conference

Wasserburg, Germany: – Pharmaceutical lactose specialist MEGGLE Excipients & Technology (MEGGLE) is returning as an exhibitor to the influential Farmacosmética 2018 in Medellin, Colombia.

MEGGLE will bring to the event a selected range of lactose anhydrous and lactose monohydrate-based pharmaceutical grade excipients that are vital components in processes across the pharmaceutical and cosmetics industries.

Lactose based co-processed excipients

In partnership with its exclusive Colombian distributor, Händler S.A.S., MEGGLE will be exhibiting at booths 135 and 136 at the Medellin Expo Center.

The MEGGLE display will cover a huge range of advanced lactose-based ingredients and excipients with particular emphasis on lactose based co-processed excipients Cellactose®80, MicroceLac®100, StarLac®, CombiLac® and RetaLac®, a ground-breaking hypromellose-lactose base for enhanced controlled release in oral dispersible tablet (ODT) and oral sustained release formulations.

Value-added offers

MEGGLE will also present its range of value-added technical consultancy and troubleshooting services.

Managing Director of MEGGLE Latin America, Fábio Luis Ikuno, will be a prominent presence on the stand.

This is a key platform from which to reach out to the research and development, pharmacotechnical, purchasing and production communities within the pharma industry in Colombia and across Latin America,” commented Mr. Ikuno.

“We will be using the opportunity to show how we can offer them reduced development times, greater efficiency, enhanced quality and cost benefits,” said Mr. Ikuno.

About MEGGLE Wasserburg

Bavarian-based MEGGLE Wasserburg is one of the world’s experts in lactose based excipients and powder technology.

From its roots as a dairy operation in the late 1880s, MEGGLE has become one of the world’s leading manufacturers of pharmaceutical lactose, supplying the pharma market segment with a broad-based and unique lactose product portfolio.

MEGGLE Excipients & Technology has harnessed outstanding product quality and intelligent innovation to become a global leader in the manufacture of lactose-based excipients, focusing on products for direct tableting and dry powder inhalation.

A multidisciplinary team of committed and highly qualified people allows MEGGLE clients to benefit from pioneering experience and innovative drive in industrial milk and whey processing. The company constantly strives to develop high-tech, functional products for solid dosage form applications, where they can deliver maximum performance.

The company has introduced several pioneering products, notably Tablettose®, the world’s first agglomerated lactose for direct tableting, Cellactose® 80, a pioneering co-processed excipient based on cellulose-lactose for outstanding compression and flow properties and RetaLac®, the first direct compression co-processed excipient using a hypromellose-lactose base for modified sustained release and controlled release formulations.

About Farmacosmética 2018

The annual Farmacosmética conference provides a platform for sharing academic and commercial knowledge across the pharmaceutical and cosmetic industries. The event is one of the most important pharma events in Latin America.

It currently attracts around 1,000 attendees, representing professionals from all levels and areas of the pharma and cosmetic industries.

Farmacosmética 2018 is a three-day event opening September 20 at the Medellin Congress Center and will feature three related conferences: The XV Colombian Symposium on Cosmetic Science and Technology, the XI Congress of Pharmaceutical Sciences and the XX Congress of the South American Pharmaceutical Federation. Alongside the academic symposium and congresses, there is a co-located trade exhibition.

Farmacosmética 2018 is organized by the National College of Pharmaceutical Chemists of Colombia and the Colombian Association of Cosmetic Science and Technology with further information at: http://farmacosmetica.com.co/.